triisopropyl(((4E,6E,8E,12E)-pentadeca-4,6,8,12,14-pentaen-1-yl)oxy)silane (920019-07-4)
Identification |
Properties |
Safety Data |
|
|
Other Product
- (2E,4E,6E,8E,10E,12E)-pentadeca-2,4,6,8,10,12,14-heptaenoic acid
- 2,4,6,8,10,12-Tetradecahexaenal,14-[(1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl]-2,7,11-trimethyl-14-oxo-, (2E,4E,6E,8E,10E,12E)-
- 2,4,6,8,10,12,14,16,18-Nonadecanonaenal,19-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl]-4,8,13,17-tetramethyl-,(2E,4E,6E,8E,10E,12E,14E,16E,18E)-
- 2,4,6,8,10,12,14,16,18,20,22-Tricosaundecaenal,23-(4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-4,8,12,17,21-pentamethyl-,(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)- (9CI)
- 2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid,17-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-2,6,11,15-tetramethyl-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
- 2,4,6,8,10,12,14-Heptadecaheptaen-16-ynal,17- [(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexen- 1-yl]-2,6,11,15-tetramethyl-,(2E,4E,- 6E,8E,10E,12E,14E)-
- 2,4,6,8,10,12-Tridecahexaenal,13-[(1S,4S,6R)- 4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]- hept-1-yl]-2,7,11-trimethyl-,(2E,4E,6E,8E,- 10E,12E)-
- 2,4,6,8,10,12,14,16-Heptadecaoctaenal,2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E,14E,16E)-
- 2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E,14E,16E)-
- 2,4,6,8,10,12,14-Pentadecaheptaenal,4,9,13-trimethyl-15-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E,14E)-
- 2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, ethylester, (2E,4E,6E,8E,10E,12E,14E,16E)-
- 2,4,6,8,10,12-Tridecahexaenal,2,7,11-trimethyl-13-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E)-
- 2,4,6,8,10,12-Tridecahexaenoic acid,2,7,11-trimethyl-13-(2,6,6-trimethyl-1-cyclohexen-1-yl)-,(2E,4E,6E,8E,10E,12E)-
- triisopropyl((4-phenylbut-1-yn-1-yl)oxy)silane
- (4E,6E,8E,10E,12E)-8-Methyl-13-phenyltrideca-4,6,8,10,12-pentaene-3-one
- L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E)-14-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,14-dioxo-2,4,6,8,10,12-tetradecahexaenyl]-(9CI)
- b-D-Glucopyranoside,(1S,4E,8E,12Z)-14-[[O-6-deoxy-3-O-[(2E,6E,10E,14S)-14-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-2,6,10,14-tetramethyl-1-oxo-2,6,10,15-hexadecatetraen-1-yl]-a-L-mannopyranosyl-(1®4)-O-[6-deoxy-a-L-mannopyranosyl-(1®6)]-b-D-glucopyranosyl]oxy]-1-ethenyl-1,5,9,13-tetramethyl-4,8,12-tetradecatrien-1-yl2-O-b-D-glucopyranosyl-
- [(2S,3S,4R,6S)-6-[(2R,3S,4S,5R,6S)-6-[[(2R,4E,6E,8R,9R,11R,12S,13S,14R)-14-acetyloxy-8-hydroxy-13-methoxy-2,9-dimethyl-16-oxo-11-(2-oxoethyl)-1-oxacyclohexadeca-4,6-dien-12-yl]oxy]-4-dimethylamino-5-hydroxy-2-methyl-oxan-3-yl]oxy-4-hydroxy-2,4-dimethyl-oxan-3-yl] 3-methylbutanoate; (2R,3R)-2,3-dihydroxybutanedioic acid
- methyl (S,4Z,8E,12E,14E)-15-((4R,5S)-2,2-dimethyl-5-((Z)-pent-2-en-1-yl)-1,3-dioxolan-4-yl)-7-((triethylsilyl)oxy)pentadeca-4,8,12,14-tetraen-10-ynoate
- (2E,4E,6E,8E,10E,12E)-tetracosa-2,4,6,8,10,12-hexaenoic acid